Alterations to vascular endothelium in the optic nerve head in patients with vascular comorbidities

Experimental Eye Research

Volumn 111, Issue , 2013, Pages 50-60

  Kang, Min H ^a,b   Balaratnasingam, Chandrakumar ^a,b   Yu, Paula K ^a,b   Morgan, William H ^a   McAllister, Ian L ^a   Cringle, Stephen J ^a,b   Yu, Dao Yi ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Central retinal artery; Central retinal vein; Endothelium; Lamina cribrosa; Optic nerve

Indexed keywords

F ACTIN;

ADULT; AGED; ARTICLE; CENTRAL RETINA ARTERY; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; COMORBIDITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; MALE; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ARTERY; RETINA VEIN; VASCULAR ENDOTHELIUM;

ACTINS; ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; EYE BANKS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OPTIC DISK; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; SMOKING; STRESS FIBERS; TISSUE DONORS; YOUNG ADULT;

EID: 84876741883     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.03.005     Document Type: Article

References (72)

1. Abraham D., Dashwood M. Endothelin - role in vascular disease. Rheumatology 2008, 47(Suppl. 5):v23-v24. (Oxford).
2. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100:158-173.
3. Aird W.C. Endothelium in health and disease. Pharmacol. Rep. 2008, 60:139-143.
4. Anderson D.R. Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch. Ophthalmol. 1969, 82:800-814.
5. Anderson D.R. Ultrastructure of the optic nerve head. Arch. Ophthalmol. 1970, 83:63-73.
6. Andries L.J., Brutsaert D.L. Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton. Cell. Tissue Res. 1993, 273:107-117.
7. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512-523.
8. Balaratnasingam C., Morgan W.H., Johnstone V., Cringle S.J., Yu D.-Y. Heterogeneous distribution of axonal cytoskeleton proteins in the human optic nerve. Invest. Ophthalmol. Vis. Sci. 2009, 50:2824-2838.
9. Balaratnasingam C., Morgan W.H., Johnstone V., Pandav S.S., Cringle S.J., Yu D.-Y. Histomorphometric measurements in human and dog optic nerve and an estimation of optic nerve pressure gradients in human. Exp. Eye Res. 2009, 89:618-628.
10. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23:168-175.
11. Brummel-Ziedins K.E., Vossen C.Y., Butenas S., Mann K.G., Rosendaal F.R. Thrombin generation profiles in deep venous thrombosis. J.Thromb. Haemost. 2005, 3:2497-2505.
12. Butler P.J., Norwich G., Weinbaum S., Chien S. Shear stress induces a time- and position-dependent increase in endothelial cell membrane fluidity. Am. J. Physiol. Cell. Physiol. 2001, 280:C962-C969.
13. Califano J.P., Reinhart-King C.A. Exogenous and endogenous force regulation of endothelial cell behavior. J.Biomech. 2010, 43:79-86.
14. Cheung N., Klein R., Wang J.J., Cotch M.F., Islam A.F., Klein B.E., Cushman M., Wong T.Y. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest. Ophthalmol. Vis. Sci. 2008, 49:4297-4302.
15. Chiu J.J., Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 2011, 91:327-387.
16. Cornhill J.F., Levesque M.J., Herderick E.E., Nerem R.M., Kilman J.W., Vasko J.S. Quantitative study of the rabbit aortic endothelium using vascular casts. Atherosclerosis 1980, 35:321-337.
17. Danton G., Watson B.D., Prado R., Dietric W.D. Endothelium-targeted pharmacotherapeutics for the treatment of stroke. Curr. Opin. Investig. Drugs 2002, 3:896-904.
18. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995, 75:519-560.
19. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:III27-III32.
20. DeMaio L., Tarbell J.M., Scaduto R.C., Gardner T.W., Antonetti D.A. Atransmural pressure gradient induces mechanical and biological adaptive responses in endothelial cells. Am. J. Physiol. (Heart Circ. Physiol.) 2004, 286:H731-H741.
21. Dewey C.F., Bussolari S.R., Gimbrone M.A., Davies P.F. The dynamic response of vascular endothelial cells to fluid shear stress. J.Biomech. Eng. 1981, 103:177-185.
22. Ehringer W.D., Yamany S., Steier K., Farag A., Roisen F.J., Dozier A., Miller F.N. Quantitative image analysis of F-actin in endothelial cells. Microcirculation 1999, 6:291-303.
23. Goode T.B., Davies P.F., Reidy M.A., Bowyer D.E. Aortic endothelial cell morphology observed in situ by scanning electron microscopy during atherogenesis in the rabbit. Atherosclerosis 1977, 27:235-251.
24. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., Lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2011, 42:2672-2713.
25. Gottlieb A.I., Langille B.L., Wong M.K.K., Kim D.W. Structure and function of the endothelial cytoskeleton. Lab. Invest. 1991, 65:123-137.
26. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans. Am. Ophthalmol. Soc. 1981, 79:371-422.
27. Hadi H.A., Carr C.S., Al S.J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag. 2005, 1:183-198.
28. Halim A., Kanayama N., el M.E., Maehara K., Masahiko H., Terao T. Endothelin-1 increased immunoreactive von Willebrand factor in endothelial cells and induced micro thrombosis in rats. Thromb. Res. 1994, 76:71-78.
29. Hayreh S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog. Retin. Eye Res. 2005, 24:493-519.
30. Hayreh S.S. Acute retinal arterial occlusive disorders. Prog. Retin. Eye Res. 2011, 30:359-394.
31. Hazel A.L., Pedley T.J. Vascular endothelial cells minimize the total force on their nuclei. Biophys. J. 2000, 78:47-54.
32. Hazin R., Dixon J.A., Bhatti M.T. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?. Curr. Opin. Ophthalmol. 2009, 20:210-218.
33. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N.Engl. J. Med. 2001, 344:1608-1621.
34. Hsiai T.K., Cho S.K., Honda H.M., Hama S., Navab M., Demer L.L., Ho C.M. Endothelial cell dynamics under pulsating flows: significance of high versus low shear stress slew rates (d(tau)/dt). Ann. Biomed. Eng. 2002, 30:646-656.
35. Kang M.H., Balaratnasingam C., Yu P., Morgan W.H., McAllister I.L., Cringle S.J., Yu D.Y. Morphometric characteristics of central retinal artery and vein endothelium in the normal human optic nerve head. Invest. Ophthalmol. Vis. Sci. 2011, 52:1359-1367.
36. Kawanabe Y., Okamoto Y., Nozaki K., Hashimoto N., Miwa S., Masaki T. Molecular mechanism for endothelin-1-induced stress-fiber formation: analysis of G proteins using a mutant endothelin(A) receptor. Mol. Pharmacol. 2002, 61:277-284.
37. Kim D.W., Langille B.L., Wong M.K.K., Gotlieb A.I. Patterns of endothelial microfilament distribution in the rabbit aorta in situ. Circ. Res. 1989, 64:21-31.
38. Levesque M.J., Nerem R.M. The elongation and orientation of cultured endothelial cells in response to shear stress. J.Biomech. Eng. 1985, 107:341-347.
39. Ludman A., Venugopal V., Yellon D.M., Hausenloy D.J. Statins and cardioprotection-more than just lipid lowering?. Pharmacol. Ther. 2009, 122:30-43.
40. Marrie R.A., Rudick R., Horwitz R., Cutter G., Tyry T., Campagnolo D., Vollmer T. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010, 74:1041-1047.
41. McAllister I.L. Central retinal vein occlusion: a review. Clin. Experiment. Ophthalmol. 2012, 40:48-58.
42. McCue S., Noria S., Langille B.L. Shear-induced reorganization of endothelial cell cytoskeleton and adhesion complexes. Trends Cardiovasc. Med. 2004, 14:143-151.
43. Metea M.R., Newman E.A. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J.Neurosci. 2006, 26:2862-2870.
44. Millan J., Cain R.J., Reglero-Real N., Bigarella C., Marcos-Ramiro B., Fernandez-Martin L., Correas I., Ridley A.J. Adherens junctions connect stress fibres between adjacent endothelial cells. BMC. Biol. 2010, 8:11.
45. Mozaffarian D., Wilson P.W., Kannel W.B. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008, 117:3031-3038.
46. Nerem R.M., Levesque M.J., Cornhill J.F. Vascular endothelial morphology as an indicator of the pattern of blood flow. J.Biomech. Eng. 1981, 103:172-176.
47. Noria S., Xu F., McCue S., Jones M., Gotlieb A.I., Langille B.L. Assembly and reorientation of stress fibers drives morphological changes to endothelial cells exposed to shear stress. Am. J. Pathol. 2004, 164:1211-1223.
48. Orgul S., Gugleta K., Flammer J. Physiology of perfusion as it relates to the optic nerve head. Surv. Ophthalmol. 1999, 43:17-26.
49. Pearson J.D. Endothelial cell function and thrombosis. Baillieres Clin. Haematol. 1994, 7:441-452.
50. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 2007, 7:803-815.
51. Pollack A., Dottan S., Oliver M. The fellow eye in retinal vein occlusive disease. Ophthalmology 1989, 96:842-845.
52. Prasain N., Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc. Res. 2009, 77:53-63.
53. Rehak M., Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J.Thromb. Haemost. 2010, 8:1886-1894.
54. Rocha M., Apostolova N., Hernandez-Mijares A., Herance R., Victor V.M. Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. Curr. Med. Chem. 2010, 17:3827-3841.
55. Rudkin A.K., Lee A.W., Chen C.S. Vascular risk factors for central retinal artery occlusion. Eye (Lond.) 2010, 24:678-681.
56. R Development Core Team R: a Language and Environment for Statistical Computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
57. Schiffrin E.L. Vascular endothelin in hypertension. Vascul. Pharmacol. 2005, 43:19-29.
58. Sumagin R., Brown C.W., Sarelius I.H., King M.R. Microvascular endothelial cells exhibit optimal aspect ratio for minimizing flow resistance. Ann. Biomed. Eng. 2008, 36:580-585.
59. Sun D., Lye-Barthel M., Masland R.H., Jakobs T.C. The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse. J.Comp. Neurol. 2009, 516:1-19.
60. van Nieuw Amerongen G.P., Musters R.J., Eringa E.C., Sipkema P., van Hinsbergh V.W. Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis. Am. J. Physiol. Cell. Physiol. 2008, 294:C1234-C1241.
61. Vanhoutte P.M., Shimokawa H., Tang E.H., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. (Oxf) 2009, 196:193-222.
62. Versari D., Daghini E., Virdis A., Ghiadoni L., Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009, 32(Suppl. 2):S314-S321.
63. Vouret-Craviari V., Boquet P., Pouyssegur J., Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol. Biol. Cell. 1998, 9:2639-2653.
64. Williamson T.H. Central retinal vein occlusion: what's the story?. Br. J. Ophthalmol. 1997, 81:698-704.
65. Wong T.Y., Larsen E.K., Klein R., Mitchell P., Couper D.J., Klein B.E., Hubbard L.D., Siscovick D.S., Sharrett A.R. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology 2005, 112:540-547.
66. Xue J., Dong Q., Han X., You H., Gu Y., Lin S. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function. Ther. Apher. Dial. 2007, 11:171-176.
67. Yong V., Morgan W.H., Cooper R.L., Shaw M., Bremner A., Bulsara M., Yu D.-Y. Trends in registered blindness and its causes over 19 years in western Australia. Ophthalmic Epidemiol. 2006, 13:35-42.
68. Yu P.K., Yu D.-Y., Alder V.A., Seydel U., Su E.N., Cringle S.J. Heterogeneous endothelial cell structure along the porcine retinal microvasculature. Exp. Eye Res. 1997, 65:379-389.
69. Yu P.K., Balaratnasingam C., Cringle S.J., McAllister I.L., Provis J., Yu D.Y. Microstructure and network organization of the microvasculature in the human macula. Invest. Ophthalmol. Vis. Sci. 2010, 51:6735-6743.
70. Yu P.K., Balaratnasingam C., Morgan W.H., Cringle S.J., McAllister I.L., Yu D.Y. The structural relationship between the microvasculature, neurons, and glia in the human retina. Invest. Ophthalmol. Vis. Sci. 2010, 51:447-458.
71. Yu P.K., Tan P.E., Morgan W.H., Cringle S.J., McAllister I.L., Yu D.Y. Age-related changes in venous endothelial phenotype at human retinal artery-vein crossing points. Invest. Ophthalmol. Vis. Sci. 2012, 53:1108-1116.
72. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.